The storage and use of biomaterial samples is an important requirement for accompanying research and the acquisition of new knowledge to improve prognosis and therapy. Biobanking is explicitly recommended in official guidelines. In order to preserve the biomaterial, the patient must consent to the removal, transfer and storage of the biomaterial separately from the consent to the register. The biomaterial is taken at times at which a blood or urine sampling takes place anyway in the clinical routine. Therefore no additional interventions are necessary.
The storage and use of biomaterial samples is an important requirement for accompanying research and the acquisition of new knowledge to improve prognosis and therapy. Biobanking is explicitly recommended in official guidelines. In order to preserve the biomaterial, the patient must consent to the removal, transfer and storage of the biomaterial separately from the consent to the register. The biomaterial is taken at times at which a blood or urine sampling takes place anyway in the clinical routine. Therefore no additional interventions are necessary. Sample volumes are defined as follows: * Peripheral blood: up to a total of 150 ml distributed to a maximum of 10 morning blood samples (approximately 15 ml blood per blood sample) during the inpatient stay in the intensive care unit (fixed times are admission and discharge of the intensive care unit) * Urine: a total of up to 200 ml of catheter urine distributed to a maximum of 10 morning withdrawals during inpatient stays in the intensive care unit (defined times are admission and discharge from the intensive care unit)
Study Type
OBSERVATIONAL
Enrollment
99,999,999
Biological Database
Uniklinik RWTH Aachen
Aachen, Germany
RECRUITINGInterleukin 6 value [nmol/l]
Record of clinically relevant parameters
Time frame: 10 days
Interleukin 10 [nmol/l]
Record of clinically relevant parameters
Time frame: 10 days
Adrenomedullin value [nmol/l]
Record of clinically relevant parameters
Time frame: 10 days
Tumornekrosefaktor alpha [nmol/l]
Record of clinically relevant parameters
Time frame: 10 days
Procalcitonin [nmol/l]
Record of clinically relevant parameters
Time frame: 10 days
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.